Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2019 Aug 15;5(6):e352–e356. doi: 10.4158/ACCR-2019-0245

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2019 AACE.

PMC Copyright notice

Fig. 2. — A, Growth chart for patient 2; height in the upper panel and weight in the lower panel. Age at start of growth hormone is marked by an arrow and the time span of GnRH analog treatment is marked by a double arrow. B, Evaluation of morphology and testicular cell lineage markers in patient 2 (3.5 years of age at time of biopsy). Hematoxylin eosin (HE) staining and immunohistochemical (IHC) staining of OCT4 (marker of gonocytes), MAGE-A4 (marker of spermatogonia), SOX9 (marker of Sertoli cells), CYP11A1 (marker of Leydig cells), and COUP-TFII (marker of peritubular myoid- and Leydig cells). On all IHC images, counterstaining is with Mayer's hematoxylin, scale bar corresponds to 100 μm. GH = growth hormone; GnRH = gonadotropin-releasing hormone.